Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17828490 | 1.00 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL17828492 | 1.00 | KDM4E (0.38) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL20244108 | 0.95 | KDM4E (0.34) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL17828500 | 0.94 | KDM4E (0.38) | KDM4EATML3MBTL1RXFP1MEN1 | |
| SCHEMBL17828493 | 0.94 | KDM4E (0.38) | KDM4EATML3MBTL1RXFP1MEN1 | |
| SCHEMBL17828495 | 0.94 | KDM4E (0.38) | KDM4EATML3MBTL1RXFP1MEN1 | |
| SCHEMBL17828466 | 0.94 | KDM4E (0.39) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL17828467 | 0.94 | KDM4E (0.39) | KDM4EATML3MBTL1PTGER4RXFP1 | |
| SCHEMBL20803527 | 0.93 | KDM4E (0.32) | KDM4EATML3MBTL1PTGER4 | |
| SCHEMBL21655554 | 0.93 | KDM4E (0.32) | KDM4EATML3MBTL1PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11618722-B2 | Compound, composition, organic electroluminescent element, and electronic appliance | IDEMITSU KOSAN CO., LTD. (JP) | 2023-04-04 | — | — | US | disclosed |
| US-11271164-B2 | Compound, composition, organic electroluminescent element and electronic device | IDEMITSU KOSAN CO., LTD (JP) | 2022-03-08 | — | — | US | disclosed |
| US-20200358000-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-11-12 | — | — | US | disclosed |
| US-10547009-B2 | Organic electroluminescent element, electronic device and compound | IDEMITSU KOSAN CO., LTD. (JP) | 2020-01-28 | — | — | US | disclosed |
| US-9997717-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-06-12 | — | — | US | disclosed |
| US-9997717-B2 | Organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-06-12 | — | — | US | disclosed |
| US-20180053901-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE AND COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-22 | — | — | US | disclosed |
| US-20180053901-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE AND COMPOUND | IDEMITSU KOSAN CO., LTD. (JP) | 2018-02-22 | — | — | US | disclosed |
| EP-3276697-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE AND COMPOUND | Idemitsu Kosan Co., Ltd (JP) | 2018-01-31 | — | — | EP | disclosed |
| US-20160172601-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
| US-20160172601-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180053901-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT, ELECTRONIC DEVICE AND COMPOUND | LEF1, FRG1, CTNNA1 | KDM4E 2467/4885ATM 2666/4885L3MBTL1 1498/4885 |
| US-20200358000-A1 | COMPOUND, COMPOSITION, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | PAX2, CXXC4, XDH | KDM4E 2200/4885ATM 3205/4885L3MBTL1 2392/4885 |
| US-11618722-B2 | Compound, composition, organic electroluminescent element, and electronic appliance | FGF23, SUZ12, RPL24 | KDM4E 503/4885ATM 2534/4885L3MBTL1 3093/4885 |
| US-10547009-B2 | Organic electroluminescent element, electronic device and compound | LEF1, FRG1, CTNNA1 | KDM4E 2467/4885ATM 2666/4885L3MBTL1 1498/4885 |
| US-11271164-B2 | Compound, composition, organic electroluminescent element and electronic device | PAX2, CXXC4, XDH | KDM4E 2200/4885ATM 3205/4885L3MBTL1 2392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.